Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Besunyen Holdings Company Limited (0926.HK)
Beijing, CN
Besunyen Holdings Company Limited, established in Beijing, China, in 2000, functions as a subsidiary of Foreshore Holding Group Limited. The company's core operations encompass the research, development, production, and distribution of therapeutic tea products and pharmaceutical goods throughout the People's Republic of China. Its product range includes a variety of therapeutic teas, prominently featuring the Besunyen brand, alongside specific offerings such as herbal tea, Besunyen Detox, and Besunyen slimming tea. Furthermore, functional teas, such as Besunyen Fit Tea, are also part of its portfolio. Within its pharmaceutical segment, Besunyen markets LARLLY Orlistat for weight loss and manufactures and sells over-the-counter (OTC) medications, including the Besunyen Orlistat weight-loss capsule. Its products reach consumers via an extensive distribution network that includes OTC pharmacies, retail locations in shopping centers and supermarkets, a network of distributors and sub-distributors, and various online e-commerce channels.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.82% | +0.82% | -2.78% | +1.24% | +2.51% | +7.93% | -17.79% | -71.71% | -86.68% | -98.72% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+2.1% Q4'25: +17.8% (vs Q4'23)
-
EPS growth Packaged Foods: +14.6%+41.7% ★ Q4'25: +105.0% (vs Q4'23)
-
FCF margin FCF growth · Packaged Foods: +15.9%+7.2% Q4'25: +13.3% (vs Q4'23)
-
EBIT margin Packaged Foods: +7.9%+7.1% Q4'25: +7.8% (vs Q4'23)
-
ROIC Packaged Foods: +7.0%+7.6% ★ Q4'25: +17.2% (vs Q4'23)
-
Share dilution Packaged Foods: +0.0%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×0.10× ★ Q4'25: 0.05× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 | 3/5 | 5/5 |
| 2026-05-26 | A | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 | 3/5 | 5/5 |
| 2026-05-21 | A | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 | 3/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bing Feng | Chief Executive Officer & Executive Director | 4M | male |
| Yihong Zhao | Co-Founder, Executive Chairman & Chief Strategy Officer | 3M | male |
| Yan Gao | Co-Founder, Executive Vice Chairman & Vice President | 2M | female |
| Hongjiang Yu | Executive Vice President, Chief Financial Officer, Chief Operating Officer, Company Secretary & Executive Director | 997.3K | male |
| Pu Qin | Chief Strategy Officer & Chief Investment Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0926.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
